Christopher Sy, MD
Neurological Surgery · Sugar Land, TXNPI 1619393691
Payments from drug & device makers
Across 54 payments — averaging $1513.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$76K
- Globus Medical$4K
- Seaspine Orthopedics Corporation$709
- Johnson & Johnson$139
- Boston Scientific$88
- Alphatec Spine, Inc$83
- plus $179 from 6 others
What the payments were for
- Grants$75,00092%
- Travel & lodging$4,3485%
- Food & beverage$2,4023%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 21 | $76,089 |
| Globus Medical(2 entities) | 11 | $4,463 |
| Seaspine Orthopedics Corporation | 7 | $709 |
| Johnson & Johnson | 2 | $139 |
| Boston Scientific | 3 | $88 |
| Alphatec Spine, Inc | 3 | $83 |
| Stryker | 2 | $59 |
| Silk Road Medical, Inc. | 1 | $48 |
| AbbVie | 1 | $21 |
| Lundbeck LLC | 1 | $20 |
| Si-bone, Inc. | 1 | $18 |
| Olympus America Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAZOR X SYSTEM$75,137
- CALIBER$3,819
- Vu aPOD Prime NanoMetalene$445
- Sierra OCT$445
- Mariner$445
- XLIF$277
- INTELLIS ADAPTIVESTIM$185
- Excelsius - GPS$147
- Manta Ray$133
- O-ARM$132
- Expedium VERSE$127
- CD HORIZON SPINAL SYSTEM$124
- Pulse$113
- CD HORIZON$111
How this compares
$81,750 in reported general payments places this provider in the 85th percentile of 582 neurological surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 37 | $1,057 |
| Methocarbamol | 62 | $816 |
| Methylprednisolone | 31 | $230 |
| Gabapentin | 22 | $191 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $186 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Sugar Land
- John DormanOdessa$8.5M
- Daniel PetersonAustin$5.8M
- Daniel CurryHouston$3M
- Peter KanGalveston$1.8M
- Mirza BaigShenandoah$1.6M
- Koijan KainthThe Woodlands$1.3M
- Luis DuarteSan Angelo$1.2M
- Douglas FoxAustin$948K
- Richard MeyratDallas$883K
- Adam LewisCorpus Christi$851K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.